Menopausal Acne – Challenges And Solutions

References

• Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56–59. doi:10.1016/j.jaad.2007.06.04517945383
   PubMed Web of Science ®Google Scholar
• Khunger N, Kumar C. A clinic-epidemiological study of adult acne: is it different from adolescent acne? Indian J Dermatol Venereol Leprol. 2012;78:335–341. doi:10.4103/0378-6323.9545022565434
   PubMed Web of Science ®Google Scholar
• Zeichner JA, Baldwin HE, Cook-Bolden FE, Eichenfield LF, Fallon-Friedlander S, Rodriguez DA. Emerging issues in adult female acne. J Clin Aesthet Dermatol. 2017;10:37–46.
   PubMedGoogle Scholar
• Goulden V, Stables GI, Cunliffe WJ. The prevalence of facial acne in adults. J Am Acad Dermatol. 1999;41:577–580.10495379
   PubMed Web of Science ®Google Scholar
• Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001;15:541–545. doi:10.1046/j.1468-3083.2001.00357.x11843213
   PubMed Web of Science ®Google Scholar
• Dreno B, Thiboutot D, Layton A, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29(6):1096–1106. doi:10.1111/jdv.1266925296739
   PubMed Web of Science ®Google Scholar
• WHO. Scientific group on research on the menopause in the 1990s. WHO Technical Report Series Geneva, Switzerland, WHO 1996.
   Google Scholar
• Contestabile E, Derzko C. Canadian consensus on menopause and perimenopause. J Obstet Gynaecol Can. 2001;23:836–841.
   Google Scholar
• Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol. 2006;7:281–290. doi:10.2165/00128071-200607050-0000217007539
   PubMed Web of Science ®Google Scholar
• Dumont-Wallon G, Dreno B. Specificity of acne in women older than 25 years. Presse Med. 2008;37:585–591. doi:10.1016/j.lpm.2007.07.01418329241
   PubMed Web of Science ®Google Scholar
• Zaenglein AL. Acne Vulgaris. N Engl J Med. 2019;10(380):199–200.
   Google Scholar
• Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92:3040–3043. doi:10.1210/jc.2007-058117519304
   PubMed Web of Science ®Google Scholar
• Sluijmer AV, Heineman MJ, De Jong FH, Evers JL. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. J Clin Endocrinol Metab. 1995;80:2163–2167. doi:10.1210/jcem.80.7.76082727608272
   PubMed Web of Science ®Google Scholar
• Adashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62:20–27. doi:10.1016/S0015-0282(16)56810-18005293
   PubMed Web of Science ®Google Scholar
• Markopoulos MC, Kassi E, Alexandraki KI, Mastorakos G, Kaltsas G. Hyperandrogenism after menopause. Eur J Endocrinol. 2015;172:R79–R91. doi:10.1530/EJE-14-046825225480
   PubMed Web of Science ®Google Scholar
• Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab. 2011;96(3):623–631. doi:10.1210/jc.2010-013021177795
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847. doi:10.1210/jc.2005-021215827095
   PubMed Web of Science ®Google Scholar
• Rothman MS, Wierman ME. How should postmenopausal androgen excess be evaluated? Clin Endocrinol (Oxf). 2011;75:160.21521309
   PubMed Web of Science ®Google Scholar
• Capitanio B, Sinagra JL, Bordignon V, Cordiali Fei P, Picardo M, Zouboulis CC. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63(5):782–788. doi:10.1016/j.jaad.2009.10.01520619486
   PubMed Web of Science ®Google Scholar
• Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the life span. J Womens Health (Larchmt). 2012;21:223–230. doi:10.1089/jwh.2011.330522171979
   PubMed Web of Science ®Google Scholar
• Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141(3):333–338. doi:10.1001/archderm.141.3.33315781674
   PubMed Web of Science ®Google Scholar
• Albuquerque RG, Rocha MA, Bagatin E, Tufik S, Andersen ML. Could adult female acne be associated with modern life? Arch Dermatol Res. 2014;306:683–688. doi:10.1007/s00403-014-1482-624952024
   PubMed Web of Science ®Google Scholar
• Bagatin E, Freitas THP, Machado MCR, Ribeiro BM, Nunes S, Rocha MADD. Adult female acne: a guide to clinical practice. An Bras Dermatol. 2019;94:62–75. doi:10.1590/abd1806-4841.2019820330726466
   PubMed Web of Science ®Google Scholar
• Kim J. Review of the innate immune response in acne vulgaris: activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211(3):193–198. doi:10.1159/00008701116205063
   PubMed Web of Science ®Google Scholar
• Dréno B, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. Eur Acad Dermatol Venereol. 2018;32(Suppl 2):5–14. doi:10.1111/jdv.15043
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Harper JC, Graber EM, Thiboutot D, Silverberg NB, Eichenfield LF. Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies. Cutis. 2015;96:321–325.26682555
   PubMed Web of Science ®Google Scholar
• Rocha MA, Bagatin E. Skin barrier and microbiome in acne. Arch Dermatol Res. 2018;310:181–185. doi:10.1007/s00403-017-1795-329147769
   PubMed Web of Science ®Google Scholar
• Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006;85:1319–1340. doi:10.1016/j.fertnstert.2005.11.04616647374
   PubMed Web of Science ®Google Scholar
• Al-Ozairi E, Michael E, Quinton R. Insulin resistance causing severe postmenopausal hyperandrogenism. Int J Gynaecol Obstet. 2008;100(3):280–281. doi:10.1016/j.ijgo.2007.08.01718005967
   PubMed Web of Science ®Google Scholar
• Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83–89. doi:10.1210/jcem-72-1-831898744
   PubMed Web of Science ®Google Scholar
• Ramos-e-Silva M, Ramos-e-Silva S, Carneiro S. Acne in women. Br J Derm. 2015;172(Suppl. 1):20–26. doi:10.1111/bjd.13638
   Web of Science ®Google Scholar
• Marks R. Acne and its management beyond the age of 35 years. Am J Clin Dermatol. 2004;5(6):459–462. doi:10.2165/00128071-200405060-0001115663343
   PubMed Web of Science ®Google Scholar
• Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151(1):183–189. doi:10.1111/j.1365-2133.2004.06078.x15270889
   PubMed Web of Science ®Google Scholar
• Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2017;4:56–71. doi:10.1016/j.ijwd.2017.10.00629872679
   PubMedGoogle Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973. doi:10.1016/j.jaad.2015.12.03726897386
   PubMed Web of Science ®Google Scholar
• Sharma R, Abrol S, Wani M. Misuse of topical corticosteroids on facial skin a study of 200 patients. J Dermatol Case Rep. 2017;11(1):5–8.28539982
   PubMed Web of Science ®Google Scholar
• Kamangar F, Shinkai K. Acne in the adult female patient: a practical approach. Int J Dermatol. 2012;51(10):1162–1174. doi:10.1111/j.1365-4632.2012.05519.x22994662
   PubMed Web of Science ®Google Scholar
• Gold LS, Baldwin H, Rueda MJ, Kerrouche N, DrÉno B. Adapalene-benzoyl peroxide gel is efficacious and safe in adult female acne, with a profile comparable to that seen in teen-aged females. J Clin Aesthet Dermatol. 2016;9:23–29.
   Google Scholar
• Berson D, Alexis A. Adapalene 0.3% for the treatment of acne in women. J Clin Aesthet Dermatol. 2013;6:32–35.
   PubMedGoogle Scholar
• Thielitz A, Lux A, Wiede A, Kropf S, Papakonstantinou E, Gollnick H. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. J Eur Acad Dermatol Venereol. 2015;29:789–796. doi:10.1111/jdv.1282325399481
   PubMed Web of Science ®Google Scholar
• Berger R, Rizer R, Barba A, et al. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Clin Ther. 2007;29:1086–1097. doi:10.1016/j.clinthera.2007.06.02117692723
   PubMed Web of Science ®Google Scholar
• Kang S, Duell EA, Fisher GJ, et al. Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol. 1995;105:549–556. doi:10.1111/1523-1747.ep123234457561157
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–348.18046911
   PubMed Web of Science ®Google Scholar
• Kim BH, Lee YS, Kang KS. The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett. 2003;146:65–73. doi:10.1016/j.toxlet.2003.09.00114615068
   PubMed Web of Science ®Google Scholar
• Canavan TN, Chen E, Eleweski BE. Optimizing non-antibiotic treatments for patients with acne: a review. Dermatol Ther (Heidelb). 2016;6:555–578. doi:10.1007/s13555-016-0138-127541148
   PubMed Web of Science ®Google Scholar
• Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586–590.21637899
   PubMed Web of Science ®Google Scholar
• Schaller M, Sebastian M, Ress C, Seidel D, Hennig M. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30(6):966–973. doi:10.1111/jdv.1365226915831
   PubMed Web of Science ®Google Scholar
• Alexis AF, Burgess C, Callender VD, et al. The efficacy and safety of topical dapsone gel, 5% for the treatment of acne vulgaris in adult females with skin of color. J Drugs Dermatol. 2016;15:197–204.26885788
   PubMed Web of Science ®Google Scholar
• Kircik LH. Use of dapsone 5% gel as maintenance treatment of acne vulgaris following completion of oral doxycycline and dapsone 5% gel combination treatment. J Drugs Dermatol. 2016;15:191–195.26885787
   PubMed Web of Science ®Google Scholar
• Dréno B, Bettoli V, Ochsendorf F, et al. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies. Eur J Dermatol. 2014;24:201–209. doi:10.1684/ejd.2014.229324704684
   PubMed Web of Science ®Google Scholar
• Kircik LH. Fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% aqueous gel: long-term use in adult females with moderate acne vulgaris. J Drugs Dermatol. 2017;16:543–546.28686771
   PubMed Web of Science ®Google Scholar
• Isvy-Joubert A, Nguyen JM, Gaultier A, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol. 2017;1(27):393–398.
   Google Scholar
• Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151:941–944. doi:10.1001/jamadermatol.2015.3425796182
   PubMed Web of Science ®Google Scholar
• Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169–191. doi:10.1007/s40257-016-0245-x28155090
   PubMed Web of Science ®Google Scholar
• Grandhi R, Alikhan A. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatol Basel Switz. 2017;233(2–3):141–144. doi:10.1159/000471799
   Web of Science ®Google Scholar
• Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22:419–428. doi:10.1016/j.clindermatol.2004.03.01015556729
   PubMed Web of Science ®Google Scholar
• De Leo V, Musacchio MC, Cappelli V, et al. Hormonal contraceptives: pharmacology tailored to women’s health. Hum Reprod Update. 2016;22:634–646. doi:10.1093/humupd/dmw01627307386
   PubMed Web of Science ®Google Scholar
• de Bastos M, Stegeman BH, Rosendaal FR, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;CD010813.24590565
   PubMed Web of Science ®Google Scholar
• Salvaggio HL, Zaenglein AL. Examining the use of oral contraceptives in the management of acne. Int J Womens Health. 2010;2:69–76.21072299
   PubMedGoogle Scholar
• Słopień R, Milewska E, Rynio P, Męczekalski B. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Menopause Rev. 2018;17(1):1–4. doi:10.5114/pm.2018.74895
   Google Scholar
• Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol. 2011;77(6):688–694. doi:10.4103/0378-6323.8648222016276
   PubMed Web of Science ®Google Scholar
• Moore A, Ling M, Bucko A, Manna V, Rueda MJ. Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study.J. Drugs Dermatol. 2015;14(6):581–586.
   PubMed Web of Science ®Google Scholar
• Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149(12):1392–1398. doi:10.1001/jamadermatol.2013.272324173086
   PubMed Web of Science ®Google Scholar
• Rademaker M. Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris. Int J Dermatol. 2016;55(5):518–523. doi:10.1111/ijd.1314526471145
   PubMed Web of Science ®Google Scholar
• Lowenstein EJ. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther. 2006;19:210–223. doi:10.1111/dth.2006.19.issue-417004997
   PubMed Web of Science ®Google Scholar
• Castillo DE, Keri JE. Chemical peels in the treatment of acne: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018;11:365–372. doi:10.2147/CCID.S137788
   Web of Science ®Google Scholar
• Gold MH. Therapeutic and aesthetic uses of photodynamic therapy part two of a five-part series: lasers and light treatments for acne vulgaris promising therapies. J Clin Aesthet Dermatol. 2008;1:28–34.
   Google Scholar
• Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2008;22:267–278. doi:10.1111/j.1468-3083.2007.02503.x18221341
   PubMed Web of Science ®Google Scholar
• Patidar MV, Deshmukh AR, Khedkar MY. Efficacy of intense pulsed light therapy in the treatment of facial acne vulgaris: comparison of two different fluences. Indian J Dermatol. 2016;61:545–549. doi:10.4103/0019-5154.19011527688446
   PubMed Web of Science ®Google Scholar
• Jih MH, Friedman PM, Goldberg LH, Robles M, Glaich AS, Kimyai-Asadi A. The 1450-nm diode laser for facial inflammatory acne vulgaris: dose-response and 12-month follow-up study. J Am Acad Dermatol. 2006;55:80–87.16781297
   PubMed Web of Science ®Google Scholar
• Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2018;178:61–75. doi:10.1111/bjd.1549528338214
   PubMed Web of Science ®Google Scholar
• Chularojanamontri L, Tuchinda P, Kulthanan K, Pongparit K. Moisturizers for acne: what are their constituents? J Clin Aesthet Dermatol. 2014;7(5):36–44.
   PubMedGoogle Scholar
• Goh CL, Noppakun N, Micali G, et al. Meeting the challenges of acne treatment in asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg. 2016;9(2):85–92. doi:10.4103/0974-2077.18404327398008
   PubMedGoogle Scholar
• Shahmoradi Z, Iraji F, Siadat AH, Ghorbaini A. Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: a double-blinded randomized clinical trial. J Res Med Sci. 2013;18(2):115–117.23914212
   PubMed Web of Science ®Google Scholar
• Sinha P, Srivastava S, Mishra N, Yadav NP. New perspectives on antiacne plant drugs: contribution to modern therapeutics. Biomed Res Int. 2014;2014:301304. doi:10.1155/2014/30130425147793
   PubMed Web of Science ®Google Scholar
• Barros BS, Zaenglein AL. The use of cosmeceuticals in acne: help or hoax? Am J Clin Dermatol. 2017;18:159–163. doi:10.1007/s40257-016-0249-628063095
   PubMed Web of Science ®Google Scholar
• Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009;18(10):833–841. doi:10.1111/j.1600-0625.2009.00924.x19709092
   PubMed Web of Science ®Google Scholar